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Background: 3D bioprinting cardiac patches for epicardial transplantation are a
promising approach for myocardial regeneration. Challenges remain such as quantifying
printability, determining the ideal moment to transplant, and promoting vascularisation
within bioprinted patches. We aimed to evaluate 3D bioprinted cardiac patches
for printability, durability in culture, cell viability, and endothelial cell structural self-
organisation into networks.
Methods: We evaluated 3D-bioprinted double-layer patches using alginate/gelatine
(AlgGel) hydrogels and three extrusion bioprinters (REGEMAT3D, INVIVO, BIO X). Bioink
contained either neonatal mouse cardiac cell spheroids or free (not-in-spheroid) human
coronary artery endothelial cells with fibroblasts, mixed with AlgGel. To test the effects on
durability, some patches were bioprinted as a single layer only, cultured under minimal
movement conditions or had added fibroblast-derived extracellular matrix hydrogel
(AlloECM). Controls included acellular AlgGel and gelatin methacryloyl (GELMA) patches.
Results: Printability was similar across bioprinters. For AlgGel compared to GELMA:
resolutions were similar (200–700 µm line diameters), printing accuracy was 45 and
25%, respectively (AlgGel was 1.7x more accurate; p < 0.05), and shape fidelity was
92% (AlgGel) and 96% (GELMA); p = 0.36. For durability, AlgGel patch median survival
in culture was 14 days (IQR:10–27) overall which was not significantly affected by
bioprinting system or cellular content in patches. We identified three factors which
reduced durability in culture: (1) bioprinting one layer depth patches (instead of two
layers); (2) movement disturbance to patches in media; and (3) the addition of AlloECM
to AlgGel. Cells were viable after bioprinting followed by 28 days in culture, and all BIO
X-bioprinted mouse cardiac cell spheroid patches presented contractile activity starting
between day 7 and 13 after bioprinting. At day 28, endothelial cells in hydrogel displayed
organisation into endothelial network-like structures.
Conclusion: AlgGel-based 3D bioprinted heart patches permit cardiomyocyte
contractility and endothelial cell structural self-organisation. After bioprinting, a period
of 2 weeks maturation in culture prior to transplantation may be optimal, allowing for a
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GRAPHICAL ABSTRACT |
degree of tissue maturation but before many patches start to lose integrity. We quantify
AlgGel printability and present novel factors which reduce AlgGel patch durability (layer
number, movement, and the addition of AlloECM) and factors which had minimal effect
on durability (bioprinting system and cellular patch content).
Keywords: 3D bioprinting, spheroids, hydrogel, bioink, durability, printability, alginate, gelatin
INTRODUCTION
The latest developments in three-dimensional (3D) bioprinting
technology have led to the hope that viable 3D bioprinted
cardiac tissues could be generated to promote myocardial
regeneration (Noor et al., 2019; Roche et al., 2020). Extrusion
3D bioprinters have been widely used as a versatile tool to
deposit different cells as ‘bio-inks’ to generate complex 3D
tissues, including cardiac tissues (Zhang et al., 2016; Ong et al.,
2017a; Maiullari et al., 2018; Noor et al., 2019). This technology
promises a safe, precise, automatable and cost-effective method
to generate myocardial tissue (Noor et al., 2019; Roche et al.,
2020). Extrusion 3D-bioprinters using cell-permissive pressures
can extrude myocardial cells without prohibiting their ability
to live, mature and function in a physiological environment
(Blaeser et al., 2016). These 3D bioprinters extrude bioinks
which can be made from hydrogels (Cattelan et al., 2020;
Roche et al., 2020).
The bioink formulation is critical to determine printability (a
function of the bioink’s rheological properties which determines
how it interacts with the bioprinting process) which is important
for bioprinting without damaging the end bioprinted product
(Cattelan et al., 2020; Gillispie et al., 2020). After bioprinting,
the tissue can be cultured to allow for a period of tissue
maturation before transplantation (Roche and Gentile, 2020).
During this post-printing phase, the bioink can promote tissue
maturation, with durability in culture being an important
characteristic to predict hydrogel disintegration (Bishop et al.,
2017; Roche and Gentile, 2020), although the optimal moment
to transplant after a period in culture has not previously
been confirmed. During this phase, cardiomyocyte contractility
should be permitted and endothelial cells within the bioprinted
tissue should be permitted to organise into networks, as one
of the major challenges in 3D bioprinting of cardiac tissues
is the fabrication of a hierarchical vascular system within
tissues (Gentile, 2016; Ong et al., 2017b; Polonchuk et al.,
2017; Cui et al., 2019; Polley et al., 2020; Roche et al., 2020;
Xu et al., 2020).
Here, we present a promising approach to generate 3D
bioprinted cardiac patches presenting a structural endothelial
cell network using alginate/gelatin (AlgGel) hydrogels – a mix
of alginate (to provide an ionically cross-linkable structure for
cellular patches) and gelatin (to adapt the alginate for extrusion
3D bioprinting, control rheological properties by varying the
gelatin concentration and generate a bioactive hybrid hydrogel).
The versatility of AlgGel hydrogels is established (Mancha
Sánchez et al., 2020), balancing printability against durability
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characteristics in culture, whilst also permitting cardiomyocyte
contractility and endothelial cell network formation. The extent
to which vascular networks are able to self-assemble within
patches is closely linked to several other characteristics: 1)
printability (for instance, with poor printability, control of
patch morphology is undermined); 2) durability (if patches
disintegrate too quickly in culture then there would be no patch
to host a vascular network); 3) cell viability (since survival
of cells, including endothelial and other cell types, is critical);
and 4) contractility must be permitted (patches which inhibit
contractility of cardiomyocytes will be less suitable for co-culture
with contractile cells) (Roche et al., 2020).
We hypothesised that 3D bioprinted endothelial cells can self-
organise into structural vascular networks using our approach.
In testing this hypothesis, we aimed to demonstrate that
even a low starting density of endothelial cells will self-organise
into structural networks within 3D bioprinted patches. In this
study we report on printability, durability, cell viability and
endothelial cell network formation for 3D bioprinted endothelial
cells in AlgGel hydrogels. Our study aims at providing new
insights which may overcome common challenges in the field of
bioprinting of cardiac tissues for in vitro and in vivo applications
(Roche et al., 2020). The major finding of our study is that
the bioprinted patches generated by using our approach present
endothelial cell networks, durable structure and contractile
function between 14 and 28 days in culture. Our findings have
the potential to directly translate in vitro testing of bioprinted
cardiac patches for in vivo applications for cardiac regeneration
(Roche and Gentile, 2020).
MATERIALS AND METHODS
All procedures described in this experiment were approved
by the Animal Ethics Committee at the Northern Sydney
Local Health District (project number RESP17/55;
20/04/2017). Full methodological details are included in the
Supplementary Materials.
Cultures of Human Coronary Artery
Endothelial Cells With Fibroblasts
Human coronary artery endothelial cells (HCAECs) (Sigma-
Aldrich, MO, United States) were cultured in MesoEndo Growth
Medium (Cell Applications, San Diego, CA, United States).
Human dermal fibroblasts (HDFs) (Sigma-Aldrich, MO,
United States) were cultured in Dulbecco’s Modified Eagle
Medium (DMEM, Sigma-Aldrich, St Louis, MO, United States)
with added 10% (v/v) FBS + 1% (v/v) pen/strep + 1%
(v/v) L-glutamine. Cells were used for bioprinting between
passage four and five.
Vascularised Cardiac Spheroid
Formation From Mouse Cardiac Cells
Mouse hearts were isolated from neonatal C57Bl/6 mice
(1–5 days old), diced into 0.1–0.2 mm pieces and enzymatically
digested with the Miltenyi Biotec (Bergisch Gladbach, Germany)
neonatal heart dissociation kit according to the manufacturer’s
instructions. Isolated cells (cardiac cell types present in a whole
heart, including myocytes, endothelial cells, and fibroblasts)
were suspended in DMEM + 10% (v/v) FBS + 1% (v/v)
pen/strep + 1% (v/v) L-glutamine. VCSs were generated by
coculturing ∼4000 mouse cardiac cells (immediately after
their isolation) in 15 µl hanging drop cultures containing
DMEM + 10% (v/v) FBS + 1% (v/v) pen/strep + 1% (v/v)
L-glutamine, using Perfecta 3D R© 384-well hanging drop plates
(3D Biomatrix, Ann Arbor, MI, United States). Spheroids were
allowed to form for up to five days in hanging drops in a
humidified incubator at 37◦C with 20% (v/v) O2 and 5% (v/v)
CO2. Additional complete DMEM (7 µl) was added to each
hanging drop on day three. VCSs were collected and the resulting
spheroid suspension was centrifuged at 300 g for 5 mins in a 50 ml
Falcon tube. The resulting VCS pellet was ready for direct mixing
with hydrogel to create bioink.
Hydrogel Preparation
To prepare the alginate and gelatin (AlgGel) hydrogel 4 mg
alginate and 8 mg gelatin powder was sterilised under UV light
for 30 min, solubilised at 50◦C in 100 ml DMEM + 10% (v/v)
FBS + 1% (v/v) pen/strep + 1% (v/v) L-glut. The mixture was
then either stored at 4◦C or used for bioink immediately after.
AlloECM hydrogel (AlloECM R©, ROKIT, Seoul, South Korea) was
prepared by adding AlloECM powder to AlgGel hydrogel at
5 and 30 mg/ml. The AlloECM-AlgGel was resuspended and
mixed thoroughly in a Falcon tube at room temperature, warmed
to 37◦C in a water bath and then was used immediately for
bioprinting. Gelatin-methacryloyl (GelMA) 10% w/v + lithium
phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) 0.25% (w/v)
in HEPES buffer in light-blocking pneumatic 3 ml syringes
was purchased (product no. IK305202, CELLINK Life Sciences,
Boston, MA, United States) for use without cells as a printability
and durability control hydrogel.
Generation of Bioinks
To create bioinks for bioprinting, hydrogels were added to pellets
of either mouse cardiac cell spheroids or a mixture of HCAECs
and HDFs (2:1), obtained as described above. 1.5 ml prewarmed
(37◦C) hydrogel was added to the cell pellet by pipette, of
which 0.5 ml typically produced six 10 mm2 patches. Each
patch contained either ∼20,000 HCAECS and ∼10,000 HDFs,
or ∼160,000 mouse cardiac cells (∼40 spheroids/patch). The
hydrogel was resuspended until the cell pellet disappeared to
ensure incorporation of most of the cells. All procedures were
performed under a biological safety cabinet for the REGEMAT3D
bioprinter. For the INVIVO and BIO X bioprinters (which have
their own UV steriliser and hepafilter) this was performed within
the bioprinting chamber itself.
3D Bioprinting
Bioprinting was performed as fully described in the
Supplementary Materials (including preparation, parameter
setting and bioprinting processes for the three bioprinters).
AlgGel was ionically crosslinked by adding CaCl2 after
bioprinting of all the patches in one six-well plate. GelMA
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was photo-crosslinked immediately after each patch layer was
bioprinted by UV light photocuring.
Printability Assessments
Printability was measured in terms of resolution, printing
accuracy, shape fidelity (after 28 days in culture) and extrudability
for grid pattern bioprinted patches. Resolution was assessed
as the width of deposited bioink gridlines (at day one – after
crosslinking immediately after bioprinting); printing accuracy
was measured as the number of empty squares between bioink
gridlines in the grid pattern at day one (a perfect grid should have
16 empty squares between gridlines of bioink); shape fidelity was
measured as the number of empty squares remaining with time
in culture at day 28; and extrudability outcome observations were
(1) whether the nozzle dripped hydrogel between the bioprinting
of patches (yes/no) and (2) the average number of times the
nozzle was blocked requiring the nozzle to be changed per six
patches bioprinted (in series one after the other). To isolate
hydrogel printability outcomes for AlgGel, it was compared
to GelMA using the BIO X and bioprinting with hydrogel
only without cells.
Durability Measurement
To assess survival of patches in culture, patches were monitored
daily for macroscopic disintegration for up to 28 days.
Culture medium was replaced every 3–4 days and the date of
patch disintegration was recorded and time to disintegration
(durability) analysed. To evaluate the effects of layer number
on patch printability eight single-layer thickness (0.2 mm
depth) acellular AlgGels were printed as controls (without
cells). To evaluate the effect of minimising movement, 13
AlgGel HCAEC + HDF patches were generated and cultured
under minimisation of movement conditions (slow media
replacement with 1000 µl narrow-bore non-automated pipette
every 7–10 days with no transfer to a microscope for
observations) and these were left in culture until the first
two patches in the set of 13 disintegrated. To evaluate the
addition of exogenous AlloECM hydrogel to the AlgGel, 23
AlloECM + AlgGel patches were printed at low and high
concentration of AlloECM. In addition, 13 acellular gelatin-
methacryloyl (GelMA) patches were produced as an extended
durability control as GelMA is more durable in culture.
Cell Viability Assays, Imaging and
Analysis
To assess cell survival, we evaluated cell viability in bioprinted
patches after 28 days in culture by staining them with
calcein-AM, ethidium homodimer (Live/Dead Assay, Invitrogen,
Carlsbad, CA, United States) and Hoechst stain, used to identify
live, dead and total cells (nuclei), respectively. Patches in
media with stains added were incubated at 37◦C for 1 h.
After fresh media replacement, patches within the plate were
moved to a microscope for automatic fluorescence imaging
by several automated microscopic methods (using an M7000
or EVOS Fl AUTO 1 (ThermoFisher, MA, United States),
Nikon Ti (Nikon, Tokyo, Japan), or IN Cell Analyzer (GE
Life Sciences, IL, United States) to obtain images of the
entire patches. Quantification of stained cells was performed by
random grid sampling and computer-based estimation using FIJI
(ImageJ) software.
Patch Contractile Activity Evaluation
To observe contractile activity, patches were monitored by video
light microscopy for intrinsic oscillations. When contractile
oscillations were observed, phase contrast microscopy video
recordings were obtained using an Olympus CKX53 microscope
(Olympus, Tokyo, Japan), with the beating patch contrasted with
non-contractile hydrogel in the same conditions. To count the
rate of beating activity, videos were played in slow motion and
the average rate taken from multiple samples.
3D Bioprinted Cell Staining, Imaging and
Analysis
To evaluate endothelial cell organisation into structural networks,
we stained bioprinted patches with antibodies against CD31 to
identify any structural endothelial cell network-like formation
after 28 days in culture. After 28 days HCAEC + HDF-
containing and mouse VCS patches were first fixed and
then stained using antibody against human/mouse CD31 and
Hoechst stain for endothelial cells and nuclei, respectively
(see Supplementary Materials for full protocol). They were
imaged by light microscopy and with a confocal microscope
(LSM 800, Zeiss, Oberkochen, Germany). Images were analysed
with ImageJ (NIH, Bethesda, United States). For 3D rendering
analysis, confocal images were processed by Imaris v7.6 (Oxford
Instruments, Zurich, Switzerland).
Statistical Analysis
Results were analysed using PRISM (GraphPad, San Diego,
CA, United States). Hypothesis testing for categorical data
was performed using the chi-square test. Hypothesis testing
for continuous data was performed using the two-tailed
Mann–Whitney U test or the Kruskal–Wallis test for a
difference between two or any of three non-parametric
data groups, respectively. Descriptive statistics (Kaplan–Meier




To evaluate printability outcomes such as resolution, printing
accuracy, shape fidelity and extrudability, 5 × 5 line grid
patches were bioprinted instead of patches completely filled with
bioink, so that these printability measures could be assessed.
Patches were bioprinted with a geometry of 10 × 10 × 0.4 mm
(length x width x depth) as shown in Figure 1. For all
three bioprinters, printability outcomes (resolution, printing
accuracy, shape fidelity and extrudability) were similar. For
AlgGel hydrogel patches, resolution was similar compared to
GelMA; printing accuracy was higher for AlgGel with 78/176
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(45%) of AlgGel empty internal squares in the grid pattern
preserved at day one compared to 53/208 (25%) for GelMA
(p < 0.05; χ2 test; n = 384); shape fidelity after 28 days in
culture was only different if it included the increased print
accuracy for AlgGel on day one, with 72/176 (41%) of squares
remaining preserved at day 28 for AlgGel and 51/208 (25%)
for GelMA (p < 0.05; χ2 test; n = 384). However, correcting
for differences in print accuracy on day one, the 28-day shape
fidelity rate was 72/78 (92%) for AlgGel and 51/53 (96%) for
GelMA (p = 0.36; χ2 test; n = 131); for extrudability, AlgGel
dripped hydrogel from the nozzle and GelMA did not and
AlgGel had zero nozzle blockages per six patches compared to
one per six patches for GelMA (AlgGel tended toward more
flow than input software instructions and GelMA tended toward
less flow). Overall, no significant difference in printability was
observed between bioprinters but AlgGel had a 1.7x higher
printing accuracy, presented some dripping from the nozzle and
had no nozzle blockages compared to GelMA hydrogel.
Patch Durability in Culture
To assess patch survival in culture conditions following
bioprinting, patches were cultured in media at 37◦C for up
to 28 days to evaluate durability in the post-printing, pre-
transplantation phase (Figure 2). The different bioprinting
system used had little effect on the overall durability of the
resulting AlgGel patches (Figures 2E,F). Overall, median (and
IQR) for time in days to disintegration (durability) of AlgGel-
based patches in media in six-well plates was 10 (3–19) with
patches printed by the REGEMAT3D, 14 (13.5–18) with the
INVIVO, and 14 (10–28) with the BIO X (p = 0.93; Kruskal–
Wallis test for a difference in any of the three groups). The
cellular patch content (mouse VCS, free (not in spheroid)
HCAECs + HDFs or acellular hydrogel alone) also had little
effect on patch durability (p = 0.17; Kruskal–Wallis test)
(Figure 2). Kaplan–Meier survival curves suggested that the
addition of cells compared to hydrogel on its own might reduce
the number of bioprinting runs (sessions producing a set of
patches) where all patches in that run survived to 28 days
(Figures 2A–C). However, survival analyses revealed no strong
pattern for durability between different cellular contents within
the AlgGel patches.
As the bioprinting system and cellular content had minimal
effect on patch durability, pooled analysis of all AlgGel patches
was performed and median durability overall was 14 days
(interquartile range (IQR) 10-27; n = 59; p < 0.05) (Figure 2D),
whereas 13/13 GelMA control patches were intact at the end
of 28 days (p < 0.05). AlgGel acellular patches with one layer
were less durable (median survival 3 days; IQR 2.5–4 days;
n = 8; p < 0.05) than two-layer AlgGel acellular patches (median
survival 28 days; IQR 19–28; n = 20; p < 0.05) (Figure 2D). The
minimisation of movement protocol allowed AlgGel patches to
be cultured until day 66 before the end point of 2/13 of these
patches losing their integrity (unsuitable for transplantation)
was reached. The addition of AlloECM to AlgGel reduced the
durability of patches: whilst AlloECM+ AlgGel patches retained
their structure after bioprinting, 23/23 patches disintegrated
in < 1 day (Figures 2D,G). This was regardless of the AlloECM
concentration in the AlgGel hydrogel (5 or 30 mg/ml), either
in the presence or absence of cellular content (Figures 2A–C).
Overall, factors which reduced patch durability in culture were:
bioprinting patches with only one layer of depth, movement
disturbance such as during media changes and transfer to a
microscopy platform and the addition of AlloECM. Factors
which had negligible impact on durability in culture were the
bioprinting system used and the cellular content.
Cell Viability
To evaluate cell survival within patches at 28 days, our analysis of
epifluorescence microscopy images at low magnification showed
viable cells surrounded by hydrogel components of the patches
which were variably autofluorescent (Figure 3). By random grid
sampling, estimated live cell density was ∼80 cells/mm2/layer
(∼16,000 cells per patch) which is a viability rate of ∼53% from
the ∼30,000 cells per patch on initial bioprinting. We measured
a live/dead ratio equal ∼2.3 at 28 days for these human cells.
Viability in mouse mixed cardiac cell (VCS) patches (Figure 4)
could not be as reliably quantified because many patch-embedded
cells were in 3D spheroids. Using a software-based analysis of
less autofluorescent confocal microscopy images we measured
a live:dead cell ratio of 9:1 for mouse VCSs. VCS diameter was
∼150 µm at 28 days in culture as shown in Figure 4. This did not
change from day one (data not shown), confirming also the fact
that VCSs maintained their shape in culture. Overall, our method
was associated with viable cells in patches, even after bioprinting
and 28 days in culture.
Patch Contractility
To assess whether patches were able to permit contractility of
cardiomyocytes, throughout the 28 day experiments all mouse
VCS-containing patches were evaluated under a light microscope
for contractile activity (Supplementary Video 1). Five patches
started to display irregular contractile activity on day seven,
two on day 10 and one on day 13. Despite six out of eight
patches breaking into fragments over the course of the 28 days,
all eight patches (or fragments) still showed some contractile
activity at the experiment end at day 28. The average rate of
(non-fragmented) patch contractions was 258 beats/min (range
230–288) and the rate did not change with time in culture.
Supplementary Video 1 shows VCS patch contractility in real-
time and the patch floating in media can be seen oscillating
compared to adjacent static areas of non-contractile hydrogel
on the well floor. Altogether, the contractility observed in our
neonatal mouse VCS-AlgGel patches suggests that there is no
barrier in principle to generating contractile cardiac tissue using
cardiac spheroids in AlgGel hydrogel (Supplementary Video 1).
Patch Endothelial Cell Network
Structural Organisation
To assess CD31+ endothelial cells’ ability to self-organise into
structural networks, we observed for network formation in VCS-
containing patches and patches with freely suspended HCAECs
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FIGURE 1 | Assessing printability for extrusion 3D bioprinting with AlgGel hydrogels and GelMA. (A–C) Representative images of 10 mm2 AlgGel patches 3D
bioprinted using three different bioprinters: a custom-made REGEMAT3D (A), the ROKIT INVIVO (B), and the CELLINK BIO X (C). The resolution (line width) of the
bioprinted grid patches was between 200 and 700 µm. Printing accuracy of AlgGel (D) and GelMA (E) was measured as the number of empty squares preserved
(Continued)
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FIGURE 1 | Continued
(black asterisks) between lines of bioink (white arrow) compared to the blueprint instructions input into the software on day one (D) inset panel). Hydrogel filled seven
of the intended 16 empty spaces in (D), whereas in (E) two were filled (white asterisks): an example of a printing accuracy of 56 and 88% for these individually
displayed representative patches, respectively. The day one GelMA patch in (E) is shown after 28 days in culture in (F), still with two spaces filled (a shape fidelity of
100% for this displayed representative patch by this measure). The black dots (white arrowheads) in (D) and (E) are air bubbles. Scale bars not shown (all patches
1 cm2). Overall in the complete sample (from which these displayed representative patches are taken), printing accuracy was higher for AlgGel with 78/176 (45%) of
AlgGel empty internal squares in the grid pattern preserved at day one compared to 53/208 (25%) for GelMA (p < 0.05; χ2 test; n = 384); shape fidelity after
28 days in culture was only different if it included the increased print accuracy for AlgGel on day one, with 72/176 (41%) of squares remaining preserved at day 28 for
AlgGel and 51/208 (25%) for GelMA (p < 0.05; χ2 test; n = 384). However, correcting for differences in print accuracy on day one, the 28-day shape fidelity rate was
72/78 (92%) for AlgGel and 51/53 (96%) for GelMA (p = 0.36; χ2 test; n = 131).
FIGURE 2 | Durability assessments for 3D bioprinted patches in cell culture medium up to 28 days. (A–C) Survival analyses grouped by different patch cellular
content, either hydrogel without cells (A), with HCAECs and HDFs (B) or mouse cardiac cell in VCSs (C). All curves are statistically significant compared to adjacent
curves unless marked by “ns” and a black linking line connecting two or more similar (non-significant) curves; p < 0.05 Log-rank (Mantel-Cox) test of each line
compared pairwise to each other line on the survival curve. In (A) identical curves are moved off centre to prevent complete line overlap (applies to AlloECM and
GelMA curves). Each curve represents one print run of a series of patches bioprinted one after the other from the same batch of hydrogel (n = 5–13 per group). As
cellular content had negligible influence on patch durability, pooled analysis of all patches is shown in (D). Overall, these results show that survival was similar
whether patches contained AlgGel alone or with cells (A–C). They also show that AlgGel had a median survival of 14 days in culture overall (D), which was reduced
by bioprinting single layer patches instead of standard thickness (double layer) or the addition of AlloECM (fibroblast-derived extracellular matrix hydrogel). Compared
to GelMA (which is more durable in culture) AlgGel presented a median survival showing that it is likely to need transplanting sooner (at 14 days in culture), because
leaving patches to culture for 28 days risks many patches fragmenting and becoming unsuitable for transplantation.
with HDFs, stained for CD31+ cells. For VCS patches, our
confocal analysis showed that some CD31+ mouse cardiac
endothelial cells in VCS remained in spheroids even after
bioprinting and 28 days in culture (Figure 4D). The median
length of CD31+ linear human endothelial cell structures was
149 µm (IQR 91–225 µm), median width was 46 µm (IQR
29–80 µm) and CD31+ endothelial cell covered area in the
hydrogel was ∼2.7%. For these patches (which contained VCS),
the CD31+ endothelial cells did not present extensive endothelial
cell organisation into networks (Figure 4), despite some of the
cells moving out of their spheroids (Figure 4D), consistent with
observations in a previous study (Fleming et al., 2010). Some
migrating CD31+ mouse cardiac endothelial cells (or clusters of
these cells) were observed within the bioprinted patch outside
of spheroids, suggesting that at day 28 patches contained a
mixture of cells which had migrated from their spheroids into the
hydrogel, cell clusters which had moved away from their initial
spheroid and cells which had remained in the same spheroids
present at the initial bioprinting (Figure 4).
Conversely, CD31+ free (not in spheroid) HCAECs started
to organise into structures resembling endothelial cell networks
(Figures 5, 6 and Supplementary Video 2). The median length of
CD31+ linear human endothelial cell structures was 88 µm (IQR
62–114 µm), median width was 37 µm (IQR 29–59 µm) and
CD31+ endothelial cell covered area in the hydrogel was ∼2.1%.
3D rendering structural analysis revealed a lumen-like space
between endothelial surfaces with endothelial cells having the
appearance of branched structures (Figure 6 and Supplementary
Video 2). Taken together, these findings suggest that (1) AlgGel
hydrogels combined with this method permit the structural self-
organisation of endothelial cells within bioprinted patches even
without additional interventions such as supplementation with
angiogenic growth factors and (2) endothelial cells in spheroids
with no additional angiogenic factors do not fully migrate out
into the surrounding hydrogel for as significant a structural
organisation into networks to occur – instead the endothelial cells
form an irregular distribution across the patch (Figure 4) and
some remain in spheroids (Figure 4D).
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FIGURE 3 | Bioprinted HCAECs and HDFs in AlgGel hydrogel are viable at 28 days. HCAEC + HDFs within a patch 3D bioprinted with the REGEMAT3D shown after
28 days in culture. This patch was stained with Hoechst (blue—nuclei), calcein-AM (green—live cell cytoplasm), ethidium homodimer (red—dead cell nuclei). Despite
hydrogel autofluorescence (white arrow), the patch shows live cells (green), and nuclei (blue) at low magnification throughout this representative segment of patch.
The live/dead ratio was ∼2.3 at 28 days in culture. Magnification bar = 500 µm.
DISCUSSION
3D bioprinting is appealing for biomedical engineering as it can
be used to produce uniform tissues, is scalable and automatable
(Roche et al., 2020). It is also adaptable for use with different
biomaterials and cell types, including iPSC-derived cardiac cells
given their potential use for heart regeneration (Roche et al.,
2020). Our study using alginate 4% (w/v)/gelatin 8% (w/v)
hydrogels and cardiac cells for 3D bioprinting of patches presents
a promising approach for cardiac bioengineering. Specifically,
supporting our hypothesis, our 3D bioprinted patches showed
that it is possible for endothelial cells to self-organise into a
structural network. Other studies have previously used differing
approaches to describe advances in endothelial cell network
assembly (Ong et al., 2017b; Cui et al., 2019; Polley et al., 2020;
Xu et al., 2020). We have added to this a 3D rendering of
micrographic data that shows endothelial cells self-organised into
a structural network with a lumen-like space with our method
(Supplementary Video 2).
Additionally, as printability and durability are important
determinants of whether the patch survives to allow for cells
to organise within it, we identified the printability/durability
impacts of several factors (bioprinting system, cellular patch
content, number of layers of patch depth, minimisation of
movement, addition of AlloECM) which had not previously been
assessed. As printability can be measured in terms of resolution
(e.g., extruded bioink line width), printing accuracy (the degree
to which bioprinted constructs match the intended construct
set by the blueprint input into the software), shape fidelity
(the ability of bioprinted constructs to maintain shape after
deposition) and extrudability (the ease of bioink extrusion/flow)
(Fisch et al., 2020; Gillispie et al., 2020), we used 5× 5 gridline
patterns instead of patches completely filled with bioink to assess
these outcome measures. For the first time in direct comparison,
we quantified that printing accuracy was 1.7x higher for AlgGel
compared to GelMA with our method which was likely related
to GelMA’s less predictable extrudability (we quantified that
GelMA complete nozzle blockages occurred on average once
every six patches compared to no blockages for AlgGel). For
durability, macroscopic disintegration (durability) was defined as
patch integrity being unacceptable for transplantation of a whole
patch – for example, using our surgical patch transplantation
method in a murine model of myocardial infarction (Roche and
Gentile, 2020) – as this is a durability indicator of practical
relevance to the surgeon transplanting patches for in vivo models.
As printability and durability are critical for generating patches
which are useable for transplantation, we thoroughly evaluated
these characteristics. GelMA was used as a durable control as it is
an established alternative to AlgGel for cardiac patch bioprinting
which is highly durable in culture (Koti et al., 2019). Other studies
have numerically described detailed rheological characteristics,
including (not limited to) storage modulus, viscosity and
extrusion pressures for similar hydrogels (Mondal et al., 2019).
Our study provides data on highly practical printability measures
(such as print accuracy) to inform hydrogel-related choices for
patch culture and subsequent transplantation.
As the effect of the bioprinting systems themselves on
our outcome measures was not previously compared, optimal
bioprinting conditions with AlgGel hydrogels were tested
with three different extrusion bioprinters: two screw-driven
extrusion systems (a custom made REGEMAT3D model and the
commercially available Rokit INVIVO) and one using pneumatic
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FIGURE 4 | CD31-positive endothelial cells within a patch containing mouse cardiac spheroids. (A–F) Laser scanning confocal microscopy (LSCM) images of a BIO
X-bioprinted AlgGel patch containing neonatal mouse cardiac spheroids stained for cell nuclei (blue) and CD31+ endothelial cells (green). Scale bars
(A–C) = 100 µm. (A) Merged channel image showing CD31+ cells across a representative segment of patch and a spheroid still intact after bioprinting followed by
28 days in culture (inset panel). (B) and (C) show CD31 stain and Hoechst stain (nuclei), respectively. (D) Magnified image of the spheroid (white arrowheads)
highlighted in panel (A). CD31 stain and Hoechst (nuclei) are shown in (E) and (F), respectively. Scale bars (D–F) = 100 µm.
extrusion (a CELLINK BIOX bioprinter) (Supplementary
Figure 1). We found that 10 × 10 × 0.4 mm patches –
sized for in vivo rodent cardiac models (Roche and Gentile,
2020) – can be 3D bioprinted with any system with minimal
difference to printability (resolution, printing accuracy, shape
fidelity and extrudability) or durability in culture. No matter
which system was in use, important parameters influencing the
printability of a bioprinted series of patches would have included
distance between the bioprinting nozzle tip and the six-well plate
surface as well as ambient temperature and hydrogel batch-to-
batch variability (see Supplementary Materials). Overall, our
results suggest that optimising bioprinting parameters was key
to the printability and long durability of patches as opposed
to the bioprinting platform used (for example, by optimisation
pre-testing to determine the ideal flow rate, nozzle speed and
temperature settings which were different for each system to
work optimally with our hydrogels). It is known that bioprinting
parameters and the concentration of AlgGel hydrogels are
established determinants of printability and durability (Mancha
Sánchez et al., 2020); our study supports this and also adds
the finding that the bioprinting system itself was not a strong
influencing factor.
We also compared different hydrogel compositions for
durable patches that readily retained their macrostructural shape
in culture conditions (Figure 2). AlgGel hydrogels are a suitable
choice for experiments that allow time for a degree of tissue
maturation in the post-printing phase before the hydrogel
disintegrates (Bociaga et al., 2019). By combining our durability
data with our time to observation of patch contractility data
(contractility was observed to begin between day seven and 13),
we are able to propose that transplantation of patches for an
in vivo model may be optimal just before 14 days in culture. Other
studies have reported related durability measures, for instance
degradation rate as % weight loss of patches in culture up to
14 days (Bociaga et al., 2019). However, ours is the first to report
a more clinically relevant durability measure based on usefulness
of the patch for its intended purpose – surgical transplantation
with an established method for in vivo testing (Roche and Gentile,
2020). Furthermore, we report comprehensive durability data
with survival beyond 14 days and present data on three previously
unevaluated determinants of durability: layer number (patch
depth), minimising movement of the patches and the addition
of an exogenous factor (AlloECM). AlloECM is a fibroblast-
derived extracellular matrix hydrogel used to mimic properties of
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FIGURE 5 | CD31-positive endothelial cell organisation within a 3D bioprinted patch containing HCAECs and HDFs. (A–C). Collapsed Z-stacks of confocal images
of a 3D bioprinted AlgGel patch stained with antibodies against CD31 (green) and Hoechst stain (blue). (A) Merged channel image of CD31+ endothelial cells (green)
and nuclei (blue) within a patch fragment. (B) CD31+ endothelial cells (white arrowhead shows border of hydrogel fragment and white asterisk shows hydrogel
containing CD31+ cells). A small T-shaped formation of endothelial cells is starting to organise, with small 1 mm branch-like formations starting to form (white
arrows). (C) The cell nuclei show the same branched organisation which maps to the CD31+ endothelial cells in (B). Magnification bars (A–C) = 200 µm.
(D) Magnified black and white image taken from inset panel in (B) shows CD31+ endothelial cells with measurements (yellow lines, measurements indicated on
image; scale bar 100 µm) and this structure is shown in more detail in the 3D rendering shown in Figure 6 and Supplementary Video 2.
the extracellular matrix. We found AlloECM could be added to
AlgGel bioprinted patches with no change to printability or patch
morphology on day one (when bioprinted). However, they all
disintegrated by the next day. Unlike the acellular AlgGel patches
which gradually broke into smaller pieces over time but left
significant pieces of patch in the well (Supplementary Figure 2),
the AlloECM-AlgGel patches were completely disintegrated into
pieces of residual hydrogel less than ∼1 mm in diameter. This
is the first time durability data have been reported for AlloECM
mixed in with AlgGel patches and the finding may have been
due to incompatibility between AlloECM and AlgGel hydrogel,
including overall pH changes or interference with the ionic
crosslinking method used. Conversely, the addition of different
cell types within a patch could also alter the microenvironment
and therefore affect durability but our data showed there was
no major durability difference depending on cell type when we
evaluated human and mouse cells in free and spheroid formation,
respectively (Figure 2). Overall, we determined that bioprinting
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FIGURE 6 | Lumen evaluation of CD31+ endothelial cells within a
3D bioprinted patch generated with alginate 4%/gelatin 8% hydrogel. (A–D) 3D
(Continued)
FIGURE 6 | rendering analysis using Imaris software of a 3D bioprinted patch
stained with antibodies against CD31 (green) and Hoechst stain (blue). (A)
and (B) 3D rendering of the endothelial structure shown previously (in
Figure 5). Scale bars 100 µm. (C) and (D) Higher magnification images
depicting the inside of the structural lumen formed by endothelial cells within a
3D bioprinted patch. (C) Arrows indicate the inner (luminal) surface of the
walls (green). Scale bar 30 µm. (D) The star indicates a pillar joining two
opposing endothelial surfaces where the lumen branches into two smaller
lumens (arrows). Scale bar 20 µm. For a full view of the 3D rendering analysis
of the same lumen formed within the 3D bioprinted patch please see
Supplementary Video 2.
platform and cellular content are not strong determinants of
durability whereas layer number, minimisation of movement in
culture media and the addition of an exogenous factor (AlloECM)
were strong determinants of durability.
For the cellular component of patches, we bioprinted some
patches with VCS which are microtissue aggregates of mixed
cardiac cell types. VCS cultures can be readily adapted for other
cell types such as stem cell-derived cells and are generated
using a scaffold-free, self-sustainable approach that allows self-
assembly and organisation of cells in 3D (Gentile, 2016).
Our evaluation of cell viability at 28 days after bioprinting
demonstrated that over time both VCS bioink and bioink
with freely suspended endothelial cells and fibroblasts could
be cultured in bioprinted hydrogel patches (Figures 3 and
4). Accurate and automated quantification of viability for
cells embedded in autofluorescent hydrogel patches in 3D is
challenging (Noor et al., 2019). Nevertheless, viability of freely
suspended cells in bioprinted patches (Figure 3) was estimated
at approximately 53–61% at day 28, comparable with previous
reports from other studies using extrusion bioprinting of 40–80%
(Murphy and Atala, 2014; Fisch et al., 2020). For VCS patches,
live cell area/total cell area was estimated at ∼72% with a
favourable ratio of live to dead cells (9:1). The inability to
accurately quantify live cells in 3D spheroids embedded in a 3D
patch limits interpretation of this result without further studies.
Future studies would benefit from measuring cell viability in
3D in a more automated way, for instance with automated
large specimen, serial confocal microscopy techniques aimed
at reducing hydrogel autofluorescence artefact. Nonetheless,
throughout our study, cells were viable in AlgGel hydrogels.
All BIO X patches containing mouse VCSs presented
contractile activity between day seven and 13 and the contractility
was transmitted across the patch (Supplementary Video 1).
We reported that the average rate for these patches was
288 beats/min. Other studies have reported a beating rate
of approximately 180 beats/min for isolated neonatal mouse
cardiomyocytes in 2D culture (Ehler et al., 2013) and 500
beats/min for live adult mice in vivo (Mahmoud et al., 2015).
For these VCS patches, our confocal images of cells migrating
from the VCS into the hydrogel (Figure 4) suggested that at
day 28 patches contained both intact VCSs and clusters of cells
which had migrated into the hydrogel. The combined presence
of cell clusters migrating away from VCSs into the hydrogel
and those remaining within VCSs may have been responsible
for the generalised contractility observed in these patches
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(Supplementary Video 1). This might explain why patches did
not beat until between one and two weeks after bioprinting,
allowing time for some cells to migrate from spheroids and make
connections across the patch. Our observed contractile activity
stopped and re-started with quiescent non-contractile periods
of a few days between. This seemed to be related to disturbing
the patches, for example when changing culture medium, which
also seemed to be a major factor in promoting macroscopic
patch disintegration as well. Nonetheless, patches (or fragments
of patches) always resumed contractile activity (all remained
contractile on day 28). We were unable to reliably measure
the electrochemical discharge which causes cardiomyocyte
contraction using our contractility-measuring and pacing system
because the patches stopped contracting during the transport to
the system platform. This was probably also due to movement
disturbance from the transport itself and for this reason our
contractility analysis was limited to observance of contractions
on video microscopy. Future workflows should minimise patch
movement as much as possible, including bioprinting directly
onto a surface suitable for electrocardiographic recording and
pacing without patch transportation.
Bioengineering of heart tissues requires a vascular network
for optimal cell survival and function (Fleming et al., 2010;
Roche et al., 2020; Wang et al., 2020) and our observations
of stained endothelial cells showed that mouse VCSs did not
organise into endothelial network structures to the same extent
as freely suspended HCAECs with HDFs (Figures 4–6 and
Supplementary Video 2). The endothelial network formation
shown in Video 2 is structurally comparable to those reported
in some other studies (Noor et al., 2019; Roche et al., 2020),
which is noteworthy given our relatively low starting density of
endothelial cells (∼2500 cells/mm3). One recent study (which
reported on endothelial cells derived from induced pluripotent
stem cells) reported a density of ∼15000 cells/mm3 (Noor et al.,
2019), so even with our HCAEC density being six-fold less, a
structural network started to form. The first clinical trial for
epicardial-transplanted patch repair in humans found that a
functional benefit may be conferred to the failing heart even
with a low starting density of stem cell derived cardiovascular
progenitor cells (410/mm3) in large (20 cm2) patches (Menasché
et al., 2018). Our study supports the notion that significant
cell growth and self-organisation can occur in patches from
a low starting cell density. For future studies, which may use
human stem cell-derived cardiac cells or spheroids, additional
factors such as vascular endothelial growth factor (VEGF) could
be added to promote endothelial cell organisation and cell
migration out of spheroids. Alternatively, a mixture of ‘free’
stem cell-derived endothelial cells and cardiac spheroids could
be used. For freely suspended endothelial cells and fibroblasts,
we used a ratio of 2:1, respectively. Whilst optimal ratios for
various cells in spheroid co-culture have been reported (Noguchi
et al., 2016; Polonchuk et al., 2017), the optimal ratio of freely
suspended HCAECS and HDFs in AlgGel is not known. The
physiological ratio of endothelial cells:fibroblasts in the heart is
not universally agreed, but the currently accepted ratio is 4:1
(Pinto et al., 2016; Zhou and Pu William, 2016). In our patches,
we doubled the number of fibroblasts relative to endothelial cells
(to increase their nourishing/supportive influence) but did not
equalise the ratio in case they interfered with endothelial cell
self-assembly – as they have previously been shown to interfere
with the functioning of other cell types (cardiomyocytes) in equal
ratio co-culture (Ong et al., 2017b). Future studies will be needed
to determine the optimal ratio of endothelial cells to fibroblasts
when freely suspended in hydrogel patches.
Future studies will also be needed to functionally test our
self-assembled endothelial cell network. If endothelial cell self-
assembly into networks is shown to be a successful approach,
it is likely to have advantages over other approaches (such as
fabricating artificial moulds and lining them with endothelial
cells). Specifically, vascular cells which self-organise following
physiological signalling in permissive hydrogel may organise
into a hierarchical network of different sized vessels and
present a more physiological network without exogenous scaffold
material. In summary, both the overall approach and the detailed
evaluations in this study pave the way for future studies aimed at
myocardial regeneration using cardiac patches.
CONCLUSION
This study provides data of high practical relevance to inform
bioengineering workflows focused on optimising cardiac patches
prior to transplantation. Specifically, we have shown that 3D
bioprinted cardiac cells are viable in alginate/gelatin hydrogels
for at least 28 days in culture, allowing endothelial cells to self-
organise into a network and for patch contractility. Bioprinted
cardiac patches in optimised conditions may develop/mature
according to physiological signals in the pre-transplant phase
even without being significantly coaxed or controlled by
additional interventions. Taking into account patch durability, we
conclude that an optimal moment to transplant patches after a
period of maturation is just before 14 days in culture.
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Supplementary Figure 1 | 3D bioprinting platforms used: a custom-made
REGEMAT3D model (left column), the ROKIT INVIVO (middle column) and the
CELLINK BIO X (right column). Hardware (A–C) and software (D–F) are shown for
these three extrusion-based 3D bioprinting systems. The REGEMAT3D
customised (D) and INVIVO ‘Creator K’ (E) software were both accessed on a
laptop computer connected to the bioprinter by USB cable and the BIO X
software (F) was entirely inbuilt on the bioprinter touchscreen.
Supplementary Figure 2 | 3D bioprinted patch fragmentation. Representative
phase images of an alginate 4%/gelatin 8% patch on day one (A) that was
fragmented in culture and became unsuitable for transplantation by day 28 (B).
Supplementary Video 1 | Beating cardiac patches containing mouse
vascularised cardiac spheroids in alginate/gelatin hydrogel. The patches shown
are oscillating in media with an average rate of 258 beats/min, consistent with
mouse cardiac cells. Oscillating patches in media are compared with
non-contractile elements such as hydrogel in the well and in the video appendices
the appearances of non-contractile patches are shown with and without extrinsic
movement applied to the microscopy apparatus.
Supplementary Video 2 | Three-dimensional rendering of CD31 + endothelial
network-like structure within an alginate/gelatin patch containing HCAECs and
HDFs. The structure shown has a lumen space and branches. These confluent
CD31 + endothelial cells (shown in green) self-assembled into this structure
over 28 days in culture following extrusion 3D bioprinting.
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